FLUVASTATIN SODIUMER (Sandoz Inc)


Welcome to the PulseAid listing for the FLUVASTATIN SODIUM drug offered from Sandoz Inc. This HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: fluvastatin sodium
SUBSTANCE NAME: FLUVASTATIN SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2015-10-16
END MARKETING DATE: 0000-00-00


FLUVASTATIN SODIUM ER HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFLUVASTATIN SODIUM ER from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 80(mg/1)
START MARKETING DATE: 2015-10-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-5370_c184692f-4afa-47b9-80d3-481fde50a4fa
PRODUCT NDC: 0781-5370
APPLICATION NUMBER: NDA021192

Other FLUVASTATIN SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Carilion Materials ManagementFluvastatin Sodium
Mylan Pharmaceuticals Inc.Fluvastatin Sodium
Novartis Pharmaceuticals CorporationLescol
Physicians Total Care, Inc.LESCOL
Sandoz IncFLUVASTATIN SODIUM
Teva Pharmaceuticals USA, Inc.Fluvastatin